ArticlePDF Available

The lollipop sign: A new cross-sectional sign of hepatic epithelioid hemangioendothelioma

Authors:

Abstract and Figures

In four cases of hepatic epithelioid hemangioendothelioma (HEHE), multiple liver lesions were depicted on enhanced computed tomography (CT) and/or magnetic resonance imaging (MRI) scans. A peculiar sign, a hepatic or portal vein terminating at or just within the periphery of some of the liver lesions, was noted in all four; the images look like a lollipop. Imaging findings of HEHE can suggest other diseases, but this sign buttressed by other radiological findings, seems to be specific for this entity.
Content may be subject to copyright.
European Journal of Radiology 59 (2006) 460–464
The lollipop sign: A new cross-sectional sign of hepatic
epithelioid hemangioendothelioma
Ahmad I. Alomari
Division of Vascular and Interventional Radiology, Department of Radiology, Children’s Hospital Boston and Harvard Medical School,
300 Longwood Ave, Boston, MA 02115, United States
Received 31 December 2005; received in revised form 19 March 2006; accepted 20 March 2006
Abstract
In four cases of hepatic epithelioid hemangioendothelioma (HEHE), multiple liver lesions were depicted on enhanced computed tomography
(CT) and/or magnetic resonance imaging (MRI) scans. A peculiar sign, a hepatic or portal vein terminating at or just within the periphery of some
of the liver lesions, was noted in all four; the images look like a lollipop. Imaging findings of HEHE can suggest other diseases, but this sign
buttressed by other radiological findings, seems to be specific for this entity.
© 2006 Elsevier Ireland Ltd. All rights reserved.
Keywords: Epithelioid hemangioendothelioma; Liver neoplasms; Diagnostic imaging
1. Introduction
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare
vascular mesenchymal neoplasm with borderline malignant
potential. Establishing the diagnosis even with histopatholog-
ical findings can be challenging.
In four patients with histologically proven HEHE, a hepatic or
portal vein tapering and terminating at or just within the edge of a
well defined peripherally enhancing (or non-enhancing) lesion
with an avascular core was seen on CT and/or MRI images,
which can be called the lollipop sign. This specific radiological
finding seems not to have been described previously.
2. Patients and methods
Eight patients with histologically proven HEHE were
referred to the Vascular Anomalies Center at Children’s Hos-
pital Boston for clinical consultation and further management.
Patients without a biopsy proven diagnosis of HEHE were
excluded from the study. Kaposiform and infantile hemangioen-
dothelioma, histologically and biologically separate entities,
were also excluded from this study.
Tel.: +1 617 355 7043; fax: +1 617 730 0541.
E-mail address: ahmad.alomari@childrens.harvard.edu.
Medical records and imaging studies on the eight patients
were reviewed retrospectively. The study was reviewed and
accepted by the hospital’s Institutional Review Board.
Five of the eight patients had at least one CT or MRI study
of the liver.
The images from these five patients were reviewed to evalu-
ate the enhancement and involvement of the hepatic and portal
veins. One histologically proven HEHE patient with completely
calcified multiple lesions of the liver was then excluded because
the presence of calcification did not allow proper evaluation of
the lesion’s core vascularity and enhancement pattern.
None of the study patients had evidence of any other malig-
nancy.
3. Results
The clinical and cross-sectional findings from the four study
patients are described below. Each had histologically proven
HEHE and demonstrated the lollipop sign.
3.1. Case 1
A 20-year-old woman presented with severe abdominal pain.
Imaging of the chest, abdomen and pelvis with enhanced CT
scans demonstrated multicentric disease involving the liver,
lungs, spine and bony pelvis. Liver function tests and tumor
0720-048X/$ – see front matter © 2006 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.ejrad.2006.03.022
A.I. Alomari / European Journal of Radiology 59 (2006) 460–464 461
Fig. 1. (a) An enhanced CT image showing multiple hypodense large parenchy-
mal nodules in both liver lobes. The nodule in Couinaud’s segment 7 demon-
strates a well-defined hypodense area with the right hepatic vein (RHV) entering
and terminating in the periphery of the lesion (arrow). This configuration resem-
bles a lollipop. The subcapsular lesion shows subtle peripheral enhancement and
extensive central hypodense area, suggestive of necrosis. Note capsular retrac-
tion as well. (b) The peripheral lesion demonstrate abrupt “cut-off” of a tributary
of the RHV at the edge of a well-defined hypodense area; another example of
the lollipop sign (arrow).
markers for common liver malignancies were unremarkable.
Percutaneous biopsy of the liver lesions showed histological
changes of HEHE. Enhanced CT scan of the liver (Fig. 1) illus-
trates the lollipop sign.
3.2. Case 2
A 20-year-old female presented at the age of 18 with a 2-
year history of a lump in the head. Skull X-rays revealed a large
osteolytic lesion in the left temporal region. Enhanced CT of
the chest, abdomen and pelvis (Fig. 2) demonstrates the lollipop
sign seen in the hepatic lesions.
3.3. Case 3
This 24-year-old woman underwent an ultrasound scan for
abdominal pain and distension. The scan showed a solitary liver
lesion. Percutaneous biopsy of the liver lesion showed histologi-
Fig. 2. An enhanced CT image showing numerous variable size hypodense large
hepatic nodules. The lesion in segment 6 (arrow) demonstrates well-defined
hypodense area with the peripheral enhancement and “cut-off” of the RHV at
its edge; a lollipop sign. Note the central hypodensity.
cal changes of HEHE. MRI of the abdomen was obtained. Fig. 3
summarizes the radiological findings.
3.4. Case 4
A 40-year-old woman presented with intermittent abdominal
pain and distension. At first, the patient was treated for a liver
abscess. The diagnosis of HEHE in this patient was consider-
ably delayed. At age 44, with the persistence of the symptoms,
imaging showed many liver and lung nodules (Fig. 4). Liver
function tests and an infectious disease workup were negative.
CT scan of the brain was normal. CT guided biopsy confirmed
the diagnosis of HEHE.
4. Discussion
In 1982, Weiss and Enzinger described 41 cases of a
unique tumor characterized by an “epithelioid” or “histiocy-
toid” endothelial cell. The majority of these tumors arise from a
medium or large sized vein. The name “epithelioid hemangioen-
dothelioma” was coined to designate this biologically borderline
neoplasm [1]. The tumor generally affects adults, with a strong
female predominance [1–4], as was seen in the study patients.
The lollipop sign presented may improve the recognition of
HEHE on cross-sectional imaging. This sign is a combination
of two structures: the hypodense well defined tumor mass on
enhanced images (the candy in the lollipop) and the histolog-
ically occluded vein (the stick). Ill-defined nodules, cavitating
lesions and complex and exophytic tumors do not exhibit this
exact finding or meet the criteria listed above. The presence of
a central enhancing scar and irregular or strong enhancement of
the lesions do not meet the criteria of the lollipop sign. The vein
should terminate smoothly at the edge or just within the rim of
the lesion. Vessels that traverse the entire lesion or are displaced
and collateral veins cannot be included in the sign.
A characteristic histological feature of HEHE is the infil-
tration of sinusoids, intrahepatic venules and veins; the tumor
surrounds the hepatic and portal veins and venules narrowing or
462 A.I. Alomari / European Journal of Radiology 59 (2006) 460–464
Fig. 3. (a) An out-of-phase MRI image shows multiple peripheral liver lesions.
The smaller lesion in the left liver lobe is uniformly hypointense with a tributary
of the left portal vein ending at is edge (arrow). The large subcapsular lesion
in the right liver lobe is more complex and heterogeneous. Central necrosis and
marked capsular retraction are evident. (b) A T2-weighted image of the liver
shows another lollipop sign composed of a hyperintense subcapsular lesion and
a hepatic vein tributary (arrow).
occluding their lumens (Fig. 5)[5–7]. Radiologically, this patho-
logical feature was documented on the all cross-sectional scans
obtained on all the four study patients. Two forms of venous
involvement are noted. The first form is smooth tapering of the
affected hepatic or portal vein in the periphery of the lesion
(Fig. 4a). The second form demonstrates complete occlusion or
“cut-off” sign of the vein at the edge of the lesion (Fig. 1b).
Recommended CT imaging protocol includes a pre-contrast
and post-contrast venous phase. The former is essential to rule
out calcification and the later to demonstrate the enhancement
pattern and the effect of the tumor on adjacent veins.
MR imaging may include T1- and T2-weighted images.
Ferumoxides-enhanced T1-weighted images more clearly define
the extent of tumor than Gadolinium-enhanced study [12].
Fig. 4. (a) A venous phase CT image of the liver showsa sharply defined lesion in
the dome of the liver. The RHV is smoothly tapering in the medial peripheral side
of the lesion (arrow). Note another smaller lesion anteromedially.Corresponding
MRI findings are seen on inversion recovery sequence (b).
Fig. 5. Gross image of native liver. A dominant lesion (large arrow) is seen
in close proximity to portal vein (PV) and inferior vena cava (IVC). Note the
occlusive effect on the adjacent PV by perivenous tumor extension. (From Ref.
[15] with permission.)
A.I. Alomari / European Journal of Radiology 59 (2006) 460–464 463
Three-dimensional reformat of the CT and multiplanar MRI
images can clearly demonstrated hepatic or portal veins orthog-
onal to the axial plane.
Common CT findings of HEHE include multifocal vari-
able size low attenuation parenchymal nodules. Two radiolog-
ical forms may be identified. A multifocal nodular pattern is
observed in the early stage. These nodules grow and coalesce,
forming large confluent masses preferentially involving the liver
periphery [8,9]. Post-contrast images may show only some
peripheral enhancement [10–12]. Calcification, central hypo-
density and capsular retraction are frequently seen. Metastatic
disease was noted in about 25–45.1% of the patients in three
large series [2,4,5]. The lungs, lymph nodes, spleen, bone and
other solid organs are among the frequent targets of HEHE
metastases.
HEHE lesions demonstrate a hypointense signal on MRI T1-
weighted sequences. The majority of the lesions showed imme-
diate peripheral post-contrast enhancement on T1-weighted
images [3,13]. Normal liver parenchymal enhancement is higher
than tumor enhancement. Central areas of hypointense signal,
similar to the CT finding, can also be noted [9]. The T2-weighted
sequence usually demonstrates heterogeneous high signal inten-
sity lesions. The degree of heterogeneity depicted with MRI is
more complex than that seen on CT images. Central areas of
reduced signal may correspond to areas of hemorrhage, coagu-
lation necrosis, and calcification [12].
The differential diagnosis of multiple liver lesions is exten-
sive. It includes congenital and infantile hemangiomas, cysts,
abscesses, hepatic peliosis, focal nodular hyperplasia, adeno-
mas, focal nodular hyperplasia, regenerating nodules, hepato-
cellular carcinoma and metastases. The latter may mimic HEHE
causing a diagnostic dilemma. However, lack of a primary malig-
nancy is a useful clinical factor in arriving at the correct diag-
nosis. This unique lollipop sign improves the specificity of the
diagnosis of HEHE since none of the lesions included in the dif-
ferential diagnosis exhibits the venous involvement and pattern
of enhancement that resemble a lollipop.
Epithelioid hemangioendothelioma is the prototype of a
group of vascular tumors characterized by an epithelioid or his-
tiocytoid endothelial cells [14]. The tumor can be difficult to
diagnose on the basis of biopsy specimens [10,13,15]. Macro-
scopically, lesions are generally white and firm, rubbery or hard
[5]. The outer margins of the tumor masses are red mottled areas
with signs of congestion [2]. Histologically, lesions are com-
posed of dendritic, intermediate and epithelioid cells [2,8].
HEHE has a variable clinical and biological course between
that of benign endothelial tumors (hemangiomas) and malig-
nant angiosarcomas [16,4] with a slowly progressive phenotype
[17]. In this study, the period between the clinical presenta-
tion and last imaging study ranged from 2 to 13 years. This
is consistent with the known indolent nature of this tumor. Clin-
ical presentation is often non-specific. Patients with HEHE can
be asymptomatic and the tumor detected incidentally. However,
symptomatic patients frequently present with right upper quad-
rant pain or weight loss, but some patients may present with
liver failure, the Budd–Chiari syndrome, or portal hypertension
[2].
Surgical resection of focal nodules the standard treatment for
focal disease and can achieve a cure. However, due to the exten-
sive liver involvement with numerous nodules or diffuse form at
the time of clinical presentation, complete surgical resection is
often impossible [18].
This study is not without limitations. Patients in this retro-
spective review were referred to our institution already having
had the imaging studies and percutaneous biopsies performed
at outside hospitals. While there were different protocols for
imaging the liver in these patients, all of them demonstrated the
lollipop sign at least in one hepatic lesion. It is important to note
that the number of patients involved in this study was limited due
to the rarity of this tumor. Further studies are needed to assess
the exact incidence of this sign in cross-sectional imaging of
HEHE.
In conclusion, HEHE may have radiological cross-sectional
findings seen with other liver lesions. While these findings may
suggest the diagnosis, the lollipop sign seem to be able to dif-
ferentiate this entity from more common liver diseases.
Acknowledgment
The author thanks Dr. N. Thorne Griscom for carefully
reviewing the manuscript.
References
[1] Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vas-
cular tumor often mistaken for a carcinoma. Cancer 1982;50(5):970–
81.
[2] Makhlouf HR, Ishak DK, Goodman ZD. Epithelioid hemangioendothe-
lioma of the liver. A clinicopathologic study of 137 cases. Cancer
1999;85(3):562–82.
[3] Leonardou P, Semelka RC, Mastropasqua M, Kanematsu M, Woosley
JT. Epithelioid hemangioendothelioma of the liver. MR imaging findings.
Magn Reson Imag 2002;20(8):631–3.
[4] Lauffer JM, Zimmermann A, Krahenbuhl L, Triller J, Baer HU. Epithe-
lioid hemangioendothelioma of the liver. A rare hepatic tumor. Cancer
1996;78(11):2318–27.
[5] Ishak KG, Sesterhenn I, Goodman ZD, Rabin L, Stromeyer W. Epithe-
lioid hemangioendothelioma of the liver: a clinicopathologic and follow-up
study of 32 cases. Hum Pathol 1984;15:839–52.
[6] Fukayama M, Nihei Z, Takizawa T, Kawaguchi K, Harada H, Koike
M. Malignant epithelioid hemangioendothelioma of the liver spreading
through the hepatic veins. Virchows Arch A Pathol Anat 1984;404:275–
87.
[7] Mermuys K, Vanhoenacker PK, Roskams T, D’Haenens P, Van Hoe L.
Epithelioid hemangioendothelioma of the liver: radiologic–pathologic cor-
relation. Abdom Imag 2004;29:221–3.
[8] Radin DR, Craig JR, Colletti PM, Ralls PW, Halls JM. Hepatic epithelioid
hemangioendothelioma. Radiology 1988;169(1):145–8.
[9] Miller WJ, Dodd III GD, Federle MP, Baron RL. Epithelioid hemangioen-
dothelioma of the liver: imaging findings with pathologic correlation. AJR
1992;159:53–7.
[10] Leonardou P, Semelka RC, Mastropasqua M, Kanematsu M, Woosley
JT. Epithelioid hemangioendothelioma of the liver. MR imaging findings.
Magn Reson Imag 2002;20(8):631–3.
[11] Kehagias DT, Moulopoulos LA, Antoniou A, Psychogios V, Vourtsi A, Vla-
hos LJ. Hepatic epithelioid hemangioendothelioma: MR imaging findings.
Hepatogastroenterology 2000;47(36):1711–3.
[12] Lyburn ID, Torreggiani WC, Harris AC, et al. Hepatic epithelioid heman-
gioendothelioma: sonographic, CT, and MR imaging appearances. AJR
Am J Roentgenol 2003;180(5):1359–64.
464 A.I. Alomari / European Journal of Radiology 59 (2006) 460–464
[13] Ramakrishna B, Loganathan G. Epithelioid haemangioendothelioma of the
liver. Ind J Pathol Microbiol 2002;45(3):329–31.
[14] Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM. Epithe-
lioid hemangioendothelioma and related lesions. Semin Diagn Pathol
1986;3(4):259–87.
[15] St Peter SD, Moss AA, Huettl EA, Leslie KO, Mulligan DC. Chemoem-
bolization followed by orthotopic liver transplant for epithelioid heman-
gioendothelioma. Clin Transpl 2003;17(6):549–53.
[16] Lencioni R, Cioni D, Crocetti L, Della Pina C, Bartolozzi C.
Magnetic resonance imaging of liver tumors. J Hepatol 2004;40(1):
162–71.
[17] Uchimura K, Nakamuta M, Osoegawa M, et al. Hepatic epithelioid heman-
gioendothelioma. J Clin Gastroenterol 2001;32(5):431–4.
[18] d’Annibale M, Piovanello P, Carlini P, et al. Epithelioid hemangioendothe-
lioma of the liver: case report and review of the literature. Transpl Proc
2002;34(4):1248–51.
... The "target sign" of HEHE on imaging has been previously defined [8,9], which is a tumour that shows a triple-ring or double-ring appearance on imaging. The "lollipop sign" is composed of a tumour and hepatic vein or portal vein around the tumour, which looks like a "lollipop" on contrast-enhanced imaging, as described by prior studies [9,10]. For multifocal lesions, we examined the largest lesion or the most typical lesion and measured their maximum long-axis diameter. ...
... Likewise, in our 15 patients, the "target sign" was detected on CT (11.1%) and MRI (87.5%). 4. In previous studies, the "lollipop sign" is considered to be the most specific sign of HEHE, which is pathologically caused by occlusion or narrowing of the hepatic vein or portal vein around tumours [9,10,13]. The tumour is similar to the body of a lollipop, and the peripheral vein represents the lollipop stick [6,30]. ...
Article
Full-text available
Objective To improve the current imaging understanding of MRI or CT for hepatic epithelioid haemangioendothelioma (HEHE) to aid in its successful preoperative diagnosis. Methods The imaging features of 15 patients (median age 38.6, range 20–71; 7 M/8 F) from eight institutions with pathologically confirmed HEHE were retrospectively analysed. Additionally, the CT/MR imaging features of 180 patients in 15 literature publications were collected, analysed and compared with our case series. Results Fifteen patients underwent CT and MRI (n = 2), CT (n = 9) or MR (n = 8) scans. A total of 92.9% (13/14) of the patients were initially diagnosed with other lesions on imaging. A total of 86.7% (13/15) were multifocal. Nodules (11/15, 73.3%) were predominantly peripheral in distribution (12/15, 80.0%). Some cases were associated with hepatic capsular retraction (13/15, 86.7%), “target signs” (8/15, 53.3%) and “lollipop signs” (5/15, 33.3%). Peripheral enhancement of various shapes in the early phase with a progressive centripetal filling was the most common pattern of enhancement (12/15, 80.0%). Abnormal vascularity was seen in 50.7% (6/15) of the patients. Suspicious tumour thromboses in the inferior vena cava were seen in 3 (20.0%) of the patients. Two of the 15 patients (13.3%) had a history of smoking. Conclusions HEHEs have common distinctive features, including multifocal lesions that are predominantly peripheral, “target signs”, “lollipop signs”, hepatic capsular retraction and peripheral enhancement of various shapes in the early phase with progressive centripetal filling. Additional aggressive imaging features that may be valuable clues to the diagnosis can be identified by CT or MRI.
... Dynamic imaging demonstrates peripheral arterial phase hyperenhancement and progressive centripetal filling in the delayed phase [4]. Alomari et al. [70] reported a series of four cases of HEHE showing a specific "lollipop sign", which is a combination of the hypodense welldefined mass on contrast-enhanced CT images representing the candy and the histologically occluded vein representing the stick. This hallmark may improve the recognition of HEHE on cross-sectional imaging, although it might be missing in a percentage of cases. ...
Article
Full-text available
Malignant focal liver lesions (FLLs) represent various kinds of epithelial and mesenchymal tumors. In pediatric patients, the understanding of pediatric liver diseases and associated imaging manifestations is essential for making accurate diagnosis and differential diagnosis. This paper will discuss the latest knowledge of the common pediatric malignant FLLs, including undifferentiated embryonal sarcoma, rhabdomyosarcoma, epithelioid hemangioendothelioma, angiosarcoma, and malignant rhabdoid tumor. Medical imaging features are not only helpful for clinical diagnosis, but can also be useful in the evaluation and follow-up of pre- and post-treatment. The future perspectives of contrast-enhanced ultrasound (CEUS) enhancement patterns of FLLs in pediatric patients are also mentioned.
... With gadolinium-enhanced MRI, the lesions may demonstrate target-type enhancement with a peripheral halo or thin peripheral hypointense rim. The "lollipop sign" seems to be specific to HEHE and indicates the aspect of a hepatic or portal vein terminating at the periphery of the liver lesions [94]. In most cases, the specificity of radiological findings is still insufficient to enable the differentiation of this exceptionally rare tumor from other FLLs, particularly from metastatic carcinoma, HCC, angiosarcoma, and atypical hepatic cavernous hemangioma. ...
Article
The diagnosis or rare mesenchymal malignant lesions of the liver may be a challenge owing to the rarity of the disease and is usually made by histological confirmation. An ultrasound examination with, if required, color Doppler sonography and contrast-enhanced ultrasound, taking into account the clinical background of the patient, may help to focus the differential diagnosis. In this review, we describe the pathological and ultrasound features of several rare mesenchymal malignant liver lesions which include undifferentiated sarcoma of the liver, leiomyosarcoma, angiosarcoma, fibrosarcoma, liposarcoma, and epithelioid hemangioendothelioma.
... Radiologic findings are often nonspecific and vary according to the site. Two characteristic computed tomography (CT) and magnetic resonance imaging (MRI) findings in hepatic EHE include the "lollipop sign", in larger lesions (>5 cm) due to bridging vein thrombosis with a rounded "head" and a tapering "tail" [6], and the "target sign", which is a lesion with a low intensity central area surrounded by a hyperintense rim, and is more likely to be found in smaller lesions (2-5 cm) [7]. Of note, benign-looking pulmonary calcification and hepatic capsular retractions are common findings in positron-emission topography (PET)/CT scans of pleural and hepatic EHE, respectively [8]. ...
Article
Full-text available
Background: Epithelioid haemangioendothelioma (EHE) is an ultra-rare malignant vascular tumour with a prevalence of 1 per 1,000,000. It is typically molecularly characterised by a WWTR1::CAMTA1 gene fusion in approximately 90% of cases, or a YAP1::TFE3 gene fusion in approximately 10% of cases. EHE cases are typically refractory to therapies, and no anticancer agents are reimbursed for EHE in Australia. Methods: We report a cohort of nine EHE cases with comprehensive histologic and molecular profiling from the Walter and Eliza Hall Institute of Medical Research Stafford Fox Rare Cancer Program (WEHI-SFRCP) collated via nation-wide referral to the Australian Rare Cancer (ARC) Portal. The diagnoses of EHE were confirmed by histopathological and immunohistochemical (IHC) examination. Molecular profiling was performed using the TruSight Oncology 500 assay, the TruSight RNA fusion panel, whole genome sequencing (WGS), or whole exome sequencing (WES). Results: Molecular analysis of RNA, DNA or both was possible in seven of nine cases. The WWTR1::CAMTA1 fusion was identified in five cases. The YAP1::TFE3 fusion was identified in one case, demonstrating unique morphology compared to cases with the more common WWTR1::CAMTA1 fusion. All tumours expressed typical endothelial markers CD31, ERG, and CD34 and were negative for pan-cytokeratin. Cases with a WWTR1::CAMTA1 fusion displayed high expression of CAMTA1 and the single case with a YAP1::TFE3 fusion displayed high expression of TFE3. Survival was highly variable and unrelated to molecular profile. Conclusions: This cohort of EHE cases provides molecular and histopathological characterisation and matching clinical information that emphasises the molecular patterns and variable clinical outcomes and adds to our knowledge of this ultra-rare cancer. Such information from multiple studies will advance our understanding, potentially improving treatment options.
... On dynamic images, the target sign consists of a hypodense/hypointense core, surrounded by a layer of enhancement and a thin peripheral hypodense/hypointense halo. The lollipop sign was a combination of two structures: the welldefined lesion on enhanced images and the adjacent occlusive vein, as HEHE has a tendency to spread within the portal and hepatic vein branches (14). The veins should terminate smoothly at or just within the edge of the lesion, vessels that throughout the entire lesion should be excluded from the signs. ...
Article
Full-text available
Objectives The aim of the present study was to describe the experience at a single institution in the management of hepatic epithelioid hemangioendothelioma (HEHE). Methods We included 51 patients with histologically confirmed HEHE. We performed log-rank (Cox–Mantel) survival analyses using Kaplan–Meier methods to test differences in survival between patients in different groups. Univariate Cox regression analyses and multivariate proportional hazards regression model were carried out to identify independent prognostic factors. Results Different imaging modalities were used to diagnose HEHE with various presentations. Liver resection (LR), liver transplantation (LT), systemic treatment (ST), and surveillance had been used in our study. A significant difference was noted between the LR group and the surveillance group with respect to mean survival (p = 0.006), as was in the LR group and the ST group (p = 0.036), and in surgical approach (LR and LT) and nonsurgical approach (ST and surveillance) (p = 0.008). The mean survival between the ST group and the surveillance group was not significantly different (p = 0.851). LR (p = 0.010) and surgical approach (p = 0.014) were favorable predictors of outcome, while macrovascular invasion (MaVI) (p = 0.037), lung metastasis (p = 0.040), and surveillance (p = 0.033) were poor prognostic factors in univariate analysis. Multivariate analysis showed that LR (p = 0.010) and surgical approach (p = 0.014) were independently associated with good OS, while surveillance (p = 0.033) was independently associated with poor OS. After adjusting for confounding factors, patients in the LR group have much better OS than those in the surveillance group (p = 0.013). However, there was no significant difference in OS between the LR group and ST group (p = 0.254), as was in the ST group and the surveillance group (p = 0.857). Conclusions The definitive diagnosis of HEHE was dependent on histopathology, and it was not possible to make a specific diagnosis without biopsy because the radiological findings were similar to those in some hepatic malignancies. ST was not recommended for patients who were not candidates for surgical approaches, and surgical approaches should be warranted regardless of disease stage. The retrospective nature and the small size of the data limited the generalizability of the study, designing a worldwide database that contains all data about patients with HEHE independent of their therapy, which was highly recommended.
... e The CT scan at 4 years after the diagnosis showed locally coalescent lesions (marked with black arrows). f The CT scan at 6 years after the diagnosis showed diffusely coalescent lesion (marked with a red arrow) be a characteristic feature of HEH [13,27]. Target sign which was depicted as two or multiple concentric layered "target-like" appearance was also reported to be a specific radiological feature of HEH [13,[28][29][30]. ...
Article
Full-text available
Background: Hepatic epithelioid hemangioendothelioma (HEH) is extremely rare, and CT features have never been analyzed in a large group of patients. Methods: A retrospective study was designed to review the contrast-enhanced CT images of HEH patients. Intrahepatic lesions were categorized into three types: nodular, locally coalescent (coalescent lesion contained in one segment) or diffusely coalescent (coalescent lesion occupied more than one segment). CT features were compared among lesions of different sizes and patients with different lesion types. Results: A total of 93 HEH patients were included in this study, and 740 lesions were analyzed. The results of per-lesion analysis showed that medium lesions (2-5 cm) had the highest rate of lollipop sign (16.8%) and target-like enhancement (43.1%), while lesions in large group (> 5 cm) had the highest rate of capsular retraction (38.8%) and vascular invasion (38.8%). The differences on enhancement pattern and the rates of lollipop sign and capsular retraction were significant among lesions of different sizes (p < 0.001, respectively). The results of per-patient analysis showed that patients in locally coalescent group had the highest rates of lollipop sign (74.3%) and target sign (94.3%). All patients in diffusely coalescent group had capsular retraction and vascular invasion. CT appearances of capsular retraction, lollipop sign, target sign and vascular invasion differed significantly among patients with different lesion types (p < 0.001, p = 0.005, p = 0.006 and p < 0.001, respectively). Conclusion: CT features variated among HEH patients with different lesion types, and radiological appearances of HEH should be classified into nodular type, locally coalescent type and diffusely coalescent type.
... Concentric zones of marked enhancement have also been reported. A visible branch of the portal or hepatic vein terminating at the periphery of these lesions (lollipop sign) has also been described, although this is not pathognomonic of the disease [83]. Lesions often become confluent and may grow large enough to replace nearly the entire liver parenchyma. ...
Chapter
Full-text available
Contrast-enhanced multi-phasic MDCT is the most important liver imaging technique in many institutions, when a focal lesion is suspected at ultrasound. Lesion characterization is based on size, shape, contour, and assessment of contrast enhancement pattern. If a lesion shows peripheral and nodular enhancement, with the density of enhancing portions similar to the vascular pool, a hemangioma can be confidently diagnosed. There are many different arterial-phase hypervascular lesions, include FNH, adenoma, HCC, and metastases from NET, melanoma, renal cell carcinoma, sarcoma, and breast cancer. Lesion characterization in general, HCC is considered in a setting of cirrhosis or chronic liver disease. An MR examination of the liver routinely includes unenhanced T1-weighted GRE DIXON, T2-weighted TSE fatsat, and diffusion-weighted imaging (DWI) as well as dynamic contrast-enhanced pulse sequences. DWI’s main clinical benefit is the detection of focal liver lesions, which may be missed on conventional and contrast-enhanced imaging sequences. Liver-specific MR contrast agents have been shown to increase the detection of liver metastases, improve the characterization of FNH and adenoma, as well as the characterization of equivocal lesions in cirrhosis.
... Concentric zones of marked enhancement have also been reported. A visible branch of the portal or hepatic vein terminating at the periphery of these lesions (lollipop sign) has also been described, although this is not pathognomonic of the disease [83]. Lesions often become confluent and may grow large enough to replace nearly the entire liver parenchyma. ...
Chapter
Full-text available
Ongoing technical innovation in combination with a broad research activity has resulted in increased adoption and widespread utilization of magnetic resonance imaging (MRI) of the prostate. The Prostate Imaging Reporting and Data System (PI-RADS), first introduced in 2012 and subsequently updated in 2015 and 2019, standardized image acquisition and reporting and facilitated the communication of imaging findings to referring physician teams and is now considered an obligatory key element in prostate MRI. This has had a tremendous impact on the diagnostic workup of patients with suspected prostate cancer. Indications for MRI have been incorporated in multiple prostate cancer guidelines (e.g., NICE, AUA, EAU, German S3-Guideline), and in turn imaging-based targeted prostate biopsy has markedly increased. Referring physicians not only heavily rely on accurate interpretation of MRI of the prostate but actively seek high-quality MRI scans for their daily practice because prostate MRI has direct impact on their cancer detection rate. Furthermore, a paradigm shift is taking place in the prostate cancer community regarding the care of low-risk prostate cancer patients, where active surveillance (AS) is increasingly favored over definitive therapy. Prostate MRI plays an important role in AS not only during the initial assessment to determine eligibility but also over the course of follow-up of the disease.
Article
The liver and biliary tree are common sites of primary and secondary malignancies. MRI followed by CT is the mainstay for the imaging characterization of these malignancies with the dynamically acquired contrast enhanced phases being the most important for diagnosis. The liver imaging reporting and data system classification provides a useful framework for reporting lesions in patents with underlying cirrhosis or who are at high risk for developing hepatocellular carcinoma. Detection of metastases is improved with the use of liver specific MRI contrast agents and diffusion weighted sequences. Aside from hepatocellular carcinoma, which is often diagnosed noninvasively, other primary hepatobiliary tumors may require biopsy for definite diagnosis, especially when presenting with nonclassic imaging findings. In this review, we examine the imaging findings of common and less common hepatobiliary tumors.
Article
Full-text available
Hepatic lesions are commonly encountered in radiology practice. Lesions with classic imaging findings such as hepatocellular carcinoma, cholangiocarcinoma, hemangiomas, focal nodular hyperplasia, and adenomas are well described in literature and easily diagnosed by most experienced radiologists. In the appropriate context, metastases, which are one of the most common lesions encountered by radiologists who practice in predominantly cancer care settings, are also easily diagnosed. However, one may encounter rarer neoplasms which may be challenging to diagnose and manage. Often, these lesions have overlapping imaging features with those of the common lesions mentioned above. Diagnosis of these rarer tumors would require not only interpreting the images in the context of patient's demographics and clinical presentation but also recognizing the unique imaging features of these tumors. The literature is sparse in describing the radiological appearances of these tumors. Diagnosis based solely on imaging criteria is not advised in these instances. Histological confirmation or other prudent follow-up strategies are necessary for confirmation of imaging findings and interpretation. In this article, we will describe known imaging features of a few rarer primary malignant and benign neoplasms in the liver.
Article
Full-text available
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare liver tumor with an indolent course relative to other hepatic malignancies. Over the past two decades, primary treatment for these lesions has been defined as resection for localized disease, or transplantation for diffuse and multifocal tumors. No published report to date has described effective pre- or post-operative adjuvant treatment for this disease. In this report, we present the first case of HEHE effectively managed with chemoembolization followed by transplantation, documenting objective tumor response to embolization. Furthermore, diagnosis for this lesion can easily be mistaken, directing management in erroneous directions. This case illustrates diagnostic pitfalls affiliated with the work-up of this tumor.
Article
Full-text available
Hepatic epithelioid hemangioendothelioma is a rare malignant neoplasm that has nonspecific clinical signs and symptoms and can be difficult to diagnose on the basis of biopsy results. Radiologists may suggest the diagnosis of this slowly progressive neoplasm by recognizing its characteristic radiologic features. We correlated images from CT (13), sonography (nine), and MR (six) with pathologic findings in resected whole livers (eight) and biopsy specimens (five) from 13 patients 25-58 years old. Gross pathologic examination showed a repetitive pattern of multiple solid tumor nodules, in a predominantly peripheral distribution, with coalescence as individual nodules exceeded 4 cm. Tumor nodules had a hyperemic rim. Lesions adjacent to the capsule often produced capsular retraction. These findings correlated well with imaging findings. On CT, the lesions were of low attenuation, peripherally based, and with capsular retraction or flattening in nine (69%) of 13 patients. Unenhanced CT scans showed superior conspicuity over contrast-enhanced CT scans (9/13, 69%) and showed the extent of lesions more accurately in all cases (13/13, 100%). In nine patients, lesions had a peripheral enhancement pattern of alternating attenuation values correlating with the hyperemic rim at pathologic evaluation. On sonograms, the tumors were solid and predominantly hypoechoic. On MR, tumor signal was low on T1-weighted and high on T2-weighted images, with a low-signal halo present around many of the lesions. CT, sonographic, or MR findings of coalescent peripheral hepatic masses with capsular retraction are highly suggestive of hepatic epithelioid hemangioendothelioma.
Article
Epithelioid hemangioendothelioma of the liver is a rare vascular tumor with intermediate malignant potential. On imaging studies, the lesion has a solid appearance and may mimic metastatic disease. We present a case in which the morphologic features (multifocal aspect, peripheral location, and capsular retraction) and the clinical history aided in including this entity in the differential diagnosis.
Article
BACKGROUND Epithelioid hemangioendothelioma (EHE) is a rare neoplasm of vascular origin that occurs in the liver and other organs; its etiology is unknown.METHODS The authors analyzed the clinicopathologic and immunohistochemical features of 137 patients with EHE of the liver in an attempt to identify features that might predict tumor behavior. To their knowledge, this article represents the largest series reported from one institution.RESULTSPatients were ages 12–86 years; 84 (61%) were females and 53 (39%) were males. They presented with nonspecific symptoms such as right upper quadrant pain or weight loss. Macroscopically, the tumors usually were multiple. They typically were white, firm to hard, and ranged in size from 0.2–14 cm. Histologically, the tumors were comprised of dendritic and epithelioid cells that often contained vacuoles representing intracellular lumina. The stroma was fibrous, with myxohyaline areas. Immunohistochemically, all tumors were positive for at least one endothelial marker (factor VIII-related antigen [FVIII-RAg], CD34, and/or CD31). Treatment modalities included hepatic resection or transplantation. Although the metastatic rate in this series was 27%, the prognosis is considered much more favorable than that of other hepatic malignancies. Twenty-six patients (43%) survived ≥ 5 years; 2 patients were alive and well at last follow-up after 23 and 27 years, respectively. Twenty-six of 60 patients (43%) died of their disease, 1 of whom died 28 years after discovery of her tumor. In an attempt to predict behavior of the tumor, several histologic parameters were evaluated using univariate analysis. No significant correlation was found with mitoses, Glisson's capsule infiltration, or nuclear atypia. High cellularity was significantly correlated with a poor clinical outcome (P = 0.00012), whereas the association with tumor necrosis approached significance (P = 0.057).CONCLUSIONSEHE is a very rare clinical entity. The key to diagnosis is the demonstration of cells containing FVIII-RAg. The histology of the tumor, including nuclear pleomorphism and the mitotic count, are of no value in predicting clinical outcome. High cellularity most likely is the most significant parameter predicting an unfavorable prognosis in EHE because mitotic counts often are quite low in both low grade and aggressive tumors. Further studies are needed to identify the factors responsible for the apparent dissociation between the clinical behavior and biologic characteristics of this tumor. Cancer 1999;85:562–82. © 1999 American Cancer Society.
Article
BACKGROUND Epithelioid hemangioendothelioma (EH) is a rare neoplasm of vascular origin that may develop at different sites, such as in soft tissue, the lungs, or the liver. It usually affects adult females, and its unpredictable malignant potential has a range between benign hemangioma and clearly malignant hemangioendotheliosarcoma.METHODS In the current study, the authors describe 2 patients with primary EH of the liver and review 127 previously published cases found in the literature.RESULTSMost patients presented with nonspecific symptoms, such as right upper quadrant abdominal pain or weight loss. The tumors usually presented as multiple nodular lesions involving both lobes of the liver. Overall metastasis rate was 45.1%, with preferential involvement of the lungs and bones. In general, the key to diagnosis was the demonstration of cells containing factor VIII-related antigen.CONCLUSIONSEH of the liver is a very rare clinical entity. The primary treatments of choice are radical hepatic resection or orthotopic liver transplantation. The 5-year survival of 55.5% is significantly better than for other hepatic malignancies. Cancer 1996;78:2318-27.
Article
Epithelioid hemangioendothelioma is a unique tumor of adult life which is characterized by an “epithelioid” or “histiocytoid” endothelial cell. Forty-one cases of this rare tumor have been recognized at the Armed Forces Institute of Pathology. They may occur in either superficial or deep soft tissue, and in 26 cases appeared to arise from a vessel, usually a medium-sized or large vein. They are composed of rounded or slightly spindled eosinophilic endothelial cells with rounded nuclei and prominent cytoplasmic vacuolization. The latter feature probably represents primitive lumen formation by a single cell. The cells grow in small nests or cords and only focally line well-formed vascular channels. The pattern of solid growth and the epithelioid appearance of the endothelium frequently leads to the mistaken diagnosis of metastatic carcinoma. The tumor can be distinguished from a carcinoma by the lack of pleomorphism and mitotic activity in most instances and by the presence of focal vascular channels. Ultrastructural study in four cases confirmed the endothelial nature of the tumor in demonstrating cells surrounded by basal lamina, dotted with surface pinocytotic vesicles, and occassionally containing Weibel-Palade bodies. Follow-up information in 31 cases indicated that 20 patients were alive and well following therapy; three developed local recurrences and six metastases. It is suggested the term epithelioid hemangioendothelioma be used to designate these biologically “borderline” neoplasms. The significance of the epithelioid endothelial cell is not entirely clear. Since it may be observed in both benign and malignant vascular lesions, its presence alone does not define a clinicopathologic entity.
Article
A case of malignant epithelioid hemangioendothelioma of the liver mimicking veno-occlusive disease is reported. The histological, ultrastructural, and immunohistochemical features of the present case indicate striking similarities to epithelioid hemangioendothelioma (EHE) of the soft parts described by Weiss and Enzinger. Tumour metastasis to the lung gave a picture closely resembling intravascular bronchiolo-alveolar tumour (IVBAT) of the lung. EHE of the liver is considered to be a unique type of hepatic endothelial neoplasm behaving as a low grade malignant tumour with a veno-occlusive process which has rarely been described, and had previously been classified as other diseases or neoplasms.
Article
Thirty-one dogs with nonlesional pruritus were treated with amitriptyline (1 mg/kg orally q12h) to determine its efficacy in the management of canine allergic pruritus. Seventeen dogs were known to be atopic, 8 were presumed to be atopic, and 6 had pruritus of undetermined etiology. Pruritus was virtually eliminated in 5 (16.1%) dogs, reduced by approximately 50% in another 5 (16.1%) dogs, and not changed in the remaining 21 dogs. Side effects were uncommon.
Article
Epithelioid hemangioendothelioma (EH) is the prototype of a group of vascular tumors characterized by an epithelioid or histiocytoid endothelial cell. This family also includes the epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia) and epithelioid forms of angiosarcoma. This review discusses the principal clinical, pathologic, and biologic differences among these three lesions. In particular the various manifestations of EH of soft tissue, bone, lung (previously called intravascular bronchioloalveolar tumor), and liver are discussed. Long-term follow-up data of EH of soft tissue and lung are provided.